{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:23:16Z","timestamp":1791562996634,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.eclinm.2020.100715","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T17:55:16Z","timestamp":1610646916000},"page":"100715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Sam","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cortina-Borja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Laugharne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Likeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7499-6029","authenticated-orcid":false,"given":"Finbar J.K.","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9114","key":"10.1016\/j.eclinm.2020.100715_bib0001","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"O'Callaghan","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100715_bib0002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"13","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100715_bib0003","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.yebeh.2007.02.004","article-title":"Psychological profile of adults with tuberous sclerosis complex","volume":"10","author":"Pulsifer","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100715_bib0004","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-8749.2002.tb00801.x","article-title":"Care of adolescents with severe learning disability from tuberous sclerosis","volume":"44","author":"Ferguson","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"5327","key":"10.1016\/j.eclinm.2020.100715_bib0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.eclinm.2020.100715_bib0006","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"Consortium","year":"1993","journal-title":"Cell"},{"issue":"50","key":"10.1016\/j.eclinm.2020.100715_bib0007","doi-asserted-by":"crossref","first-page":"35647","DOI":"10.1074\/jbc.274.50.35647","article-title":"Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin","volume":"274","author":"Nellist","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100715_bib0008","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100715_bib0009","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.ju.0000100100.36354.61","article-title":"Management of renal angiomyolipomas associated with tuberous sclerosis complex","volume":"171","author":"Harabayashi","year":"2004","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.eclinm.2020.100715_bib0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/- mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat Med"},{"issue":"10056","key":"10.1016\/j.eclinm.2020.100715_bib0011","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100715_bib0012","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100715_bib0013","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/CAD.0000000000000207","article-title":"Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening","volume":"26","author":"Trelinska","year":"2015","journal-title":"Anticancer Drugs"},{"issue":"22","key":"10.1016\/j.eclinm.2020.100715_bib0014","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.eclinm.2020.100715_bib0015","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","article-title":"Targeting the mTOR signaling network for cancer therapy","volume":"27","author":"Meric-Bernstam","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100715_bib0016","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-200565030-00005","article-title":"Oral antidiabetic agents: current role in type 2 diabetes mellitus","volume":"65","author":"Krentz","year":"2005","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.eclinm.2020.100715_bib0017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100715_bib0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100715_bib0019","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0190-9622(03)01475-0","article-title":"Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial","volume":"49","author":"Heald","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.eclinm.2020.100715_bib0020","series-title":"Vineland adaptive behavior scales","author":"Sparrow","year":"1984"},{"key":"10.1016\/j.eclinm.2020.100715_bib0021","unstructured":"https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. 2017."},{"issue":"7503","key":"10.1016\/j.eclinm.2020.100715_bib0022","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100715_bib0023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.urolonc.2011.01.003","article-title":"Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft","volume":"31","author":"Liu","year":"2013","journal-title":"Urol Oncol"},{"issue":"21","key":"10.1016\/j.eclinm.2020.100715_bib0024","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100715_bib0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100715_bib0026","doi-asserted-by":"crossref","first-page":"e31900","DOI":"10.1371\/journal.pone.0031900","article-title":"Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)","volume":"7","author":"Auricchio","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2020.100715_bib0027","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41420-020-0285-0","article-title":"Metformin effectively treats","volume":"6","author":"Fang","year":"2020","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100715_bib0028","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpn.2012.10.005","article-title":"The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex","volume":"17","author":"Amin","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.eclinm.2020.100715_bib0029","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fneur.2019.00821","article-title":"Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: results from the international TOSCA study","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.eclinm.2020.100715_bib0030","article-title":"Use of metformin and outcome of patients with newly diagnosed glioblastoma: pooled analysis","author":"Seliger","year":"2019","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100715_bib0031","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"\u0141abuzek","year":"2010","journal-title":"Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100715_bib0032","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/qjmed\/hcy215","article-title":"The UK guidelines for management and surveillance of tuberous sclerosis complex","volume":"112","author":"Amin","year":"2019","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100715_bib0033","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.703","article-title":"Drug repositioning in epilepsy reveals novel antiseizure candidates","volume":"6","author":"Brueggeman","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"10.1016\/j.eclinm.2020.100715_bib0034","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10571-018-0611-8","article-title":"Metformin plus caloric restriction show anti-epileptic effects mediated by mTOR pathway inhibition","volume":"38","author":"Rubio Osornio","year":"2018","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100715_bib0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2017.01.157","article-title":"Chronic metformin treatment facilitates seizure termination","volume":"484","author":"Yang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100715_bib0036","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-017-3806-1","article-title":"The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma","volume":"33","author":"Bissler","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"9861","key":"10.1016\/j.eclinm.2020.100715_bib0037","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100715_bib0038","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1212\/CPJ.0000000000000514","article-title":"Everolimus for treatment-refractory seizures in TSC: extension of a randomized controlled trial","volume":"8","author":"Franz","year":"2018","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.eclinm.2020.100715_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2019.11.017","article-title":"Cannabidiol elevates mechanistic target of rapamycin inhibitor levels in patients with tuberous sclerosis complex","volume":"105","author":"Ebrahimi-Fakhari","year":"2020","journal-title":"Pediatr Neurol"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020304594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020304594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:04:14Z","timestamp":1762887854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537020304594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":39,"alternative-id":["S2589537020304594"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100715","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100715"}}